BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26043699)

  • 1. SHC1 sensitizes cancer cells to the 8-Cl-cAMP treatment.
    Choi KY; Cho YJ; Kim JS; Ahn YH; Hong SH
    Biochem Biophys Res Commun; 2015 Aug; 463(4):673-8. PubMed ID: 26043699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of AMP-activated protein kinase and p38 mitogen-activated protein kinase in 8-Cl-cAMP-induced growth inhibition.
    Han JH; Ahn YH; Choi KY; Hong SH
    J Cell Physiol; 2009 Jan; 218(1):104-12. PubMed ID: 18756496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Akt2/protein kinase B β (PKBβ) in the 8-Cl-cAMP-induced cancer cell growth inhibition.
    Choi KY; Ahn YH; Ahn HW; Cho YJ; Hong SH
    J Cell Physiol; 2013 Apr; 228(4):890-902. PubMed ID: 23018889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells.
    Ahn YH; Jung JM; Hong SH
    Cancer Res; 2005 Jun; 65(11):4896-901. PubMed ID: 15930311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanisms.
    Lucchi S; Calebiro D; de Filippis T; Grassi ES; Borghi MO; Persani L
    PLoS One; 2011; 6(6):e20785. PubMed ID: 21695205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rap1 and p38 MAPK mediate 8-chloro-cAMP-induced growth inhibition in mouse fibroblast DT cells.
    Ahn YH; Han JH; Hong SH
    J Cell Physiol; 2006 Dec; 209(3):1039-45. PubMed ID: 16972264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.
    Budillon A; Di Gennaro E; Caraglia M; Barbarulo D; Abbruzzese A; Tagliaferri P
    Br J Cancer; 1999 Dec; 81(7):1134-41. PubMed ID: 10584873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-Cl-cAMP and its metabolite, 8-Cl-adenosine induce growth inhibition in mouse fibroblast DT cells through the same pathways: protein kinase C activation and cyclin B down-regulation.
    Ahn YH; Jung JM; Hong SH
    J Cell Physiol; 2004 Nov; 201(2):277-85. PubMed ID: 15334662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP-activated protein kinase facilitates avian reovirus to induce mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 3/6 signalling that is beneficial for virus replication.
    Ji WT; Lee LH; Lin FL; Wang L; Liu HJ
    J Gen Virol; 2009 Dec; 90(Pt 12):3002-3009. PubMed ID: 19656961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stearoyl lysophosphatidylcholine enhances the phagocytic ability of macrophages through the AMP-activated protein kinase/p38 mitogen activated protein kinase pathway.
    Quan H; Hur YH; Xin C; Kim JM; Choi JI; Kim MY; Bae HB
    Int Immunopharmacol; 2016 Oct; 39():328-334. PubMed ID: 27517519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism.
    Lange-Carter CA; Vuillequez JJ; Malkinson AM
    Cancer Res; 1993 Jan; 53(2):393-400. PubMed ID: 8380255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression.
    Lamb D; Steinberg RA
    J Cell Physiol; 2002 Aug; 192(2):216-24. PubMed ID: 12115728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway.
    Cao J; Cetrulo CL; Theoharides TC
    Mol Pharmacol; 2006 Mar; 69(3):998-1006. PubMed ID: 16332989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopoletin Stimulates Melanogenesis via cAMP/PKA Pathway and Partially p38 Activation.
    Kim DS; Cha SB; Park MC; Park SA; Kim HS; Woo WH; Mun YJ
    Biol Pharm Bull; 2017 Dec; 40(12):2068-2074. PubMed ID: 28943528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications.
    Ciardiello F; Tortora G
    Clin Cancer Res; 1998 Apr; 4(4):821-8. PubMed ID: 9563874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
    Rohlff C; Safa B; Rahman A; Cho-Chung YS; Klecker RW; Glazer RI
    Mol Pharmacol; 1993 Mar; 43(3):372-9. PubMed ID: 8383802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
    Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
    Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.
    Noguchi K; Murata T; Cho-Chung YS
    Eur J Cancer; 1998 Jul; 34(8):1260-7. PubMed ID: 9849489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of autophagy in hepatocellular carcinoma cells by SB203580 requires activation of AMPK and DAPK but not p38 MAPK.
    Zhang H; Chen GG; Zhang Z; Chun S; Leung BC; Lai PB
    Apoptosis; 2012 Apr; 17(4):325-34. PubMed ID: 22170404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
    Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
    Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.